Fny Investment Advisers, LLC Novo Nordisk A S Transaction History

Fny Investment Advisers, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$90.94 - $199.54 $272,820 - $598,620	3,000 New	3,000 $272,000
Q3 2022 Oct 19, 2022	BUY	$95.28 - $116.93 $3.81 Million - $4.68 Million	40,000 New	40,000 $3.99 Million
Q1 2021 Apr 12, 2021	SELL	$67.06 - $75.82 $1.27 Million - $1.43 Million	-18,900 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$63.89 - $73.8 $38,334 - $44,280	600 Added 3.28%	18,900 $1.32 Million
Q3 2020 Oct 09, 2020	BUY	$63.69 - $70.22 $764,280 - $842,640	12,000 Added 190.48%	18,300 $1.27 Million
Q2 2020 Jul 10, 2020	BUY	$58.54 - $67.94 $76,102 - $88,322	1,300 Added 26.0%	6,300 $412,000
Q1 2020 Apr 09, 2020	BUY	$49.46 - $64.78 $247,300 - $323,900	5,000 New	5,000 $301,000
Q4 2019 Jan 10, 2020	SELL	$49.86 - $58.26 $249,300 - $291,300	-5,000 Closed	0 $0
Q3 2019 Oct 25, 2019	BUY	$47.54 - $53.43 $237,700 - $267,150	5,000 New	5,000 $258,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.